Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Marketed Strip, Prototype Dilator · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Marketed nasal strip | ACTIVE_COMPARATOR | Marketed nasal strip |
| Prototype nasal dilator | EXPERIMENTAL | Prototype nasal dilator |
| Name | Type | Description |
|---|---|---|
| Marketed Nasal Strip | DEVICE | Breathe Right Nasal Strips - Clear small/medium strip |
| Prototype Nasal Dilator | DEVICE | Prototype Nasal Dilator AB2R11 |
Inclusion Criteria: * Healthy subjects
Marketed Strip, Prototype Dilator is a nasal strip prototype being studied for use in healthy subjects. It is currently in Phase 1 clinical development as an investigational product. The prototype is designed for multiple use and is being evaluated for tolerability in a clinical trial setting.
Marketed Strip, Prototype Dilator is being developed by GSK plc, a global biopharmaceutical company. GSK plc is publicly traded under the ticker symbol GSK. The company is conducting clinical research on this nasal strip prototype in the United States.
Marketed Strip, Prototype Dilator is in Phase 1 clinical development. The Phase 1 trial has been completed, and the product remains investigational. It has not been approved by regulatory authorities and is still in the early stages of clinical testing.
Marketed Strip, Prototype Dilator has one completed clinical trial, NCT01495494, titled "A Multiple Use Tolerability Study of a Breathe Right Nasal Strip Prototype." This Phase 1 study enrolled 80 healthy subjects in the United States and was active-controlled, though not double-blinded.
Marketed Strip, Prototype Dilator is not FDA approved. It is an investigational product currently in Phase 1 clinical development. The completed Phase 1 trial assessed tolerability in healthy subjects, but the product has not yet received regulatory approval for any use.